14-23386014-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_002471.4(MYH6):c.5077G>A(p.Val1693Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,614,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1693L) has been classified as Uncertain significance.
Frequency
Consequence
NM_002471.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH6 | NM_002471.4 | c.5077G>A | p.Val1693Met | missense_variant | Exon 34 of 39 | ENST00000405093.9 | NP_002462.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152224Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000107 AC: 27AN: 251292 AF XY: 0.0000957 show subpopulations
GnomAD4 exome AF: 0.000144 AC: 211AN: 1461876Hom.: 0 Cov.: 33 AF XY: 0.000140 AC XY: 102AN XY: 727246 show subpopulations
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152342Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74494 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The V1693M variant of uncertain significance in the MYH6 gene has not been published as a pathogenic or benign variant to our knowledge. This variant was not observed with any significant frequency in either the Exome Aggregation Consortium or the NHLBI Exome Sequencing Project. Nevertheless, the V1693M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution also occurs at a position where amino acids with similar properties to Valine are tolerated across species, and M1693 is tolerated in at least three species. Furthermore, the majority of in silico tools predict this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. -
Atrial septal defect 3 Uncertain:1
- -
Dilated cardiomyopathy 1EE;C2750467:Hypertrophic cardiomyopathy 14;C3279790:Atrial septal defect 3;C3279791:Sick sinus syndrome 3, susceptibility to;C3495498:Hypertrophic cardiomyopathy 1 Uncertain:1
- -
Cardiomyopathy Uncertain:1
- -
Hypertrophic cardiomyopathy 14 Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at